Oligosaccharide-linked acyl carrier protein, a novel transmethylase inhibitor, from porcine liver inhibits cell growth

Archives of Pharmacal Research

Volumn 25, Issue 4, 2002, Pages 463-468

  Dong, Wan Seo ^a   Yong, Kee Kim ^a   Cho, Eun Jung ^a   Han, Jeung Whan ^a   Hoi, Young Lee ^b   Hong, Sungyoul ^a   Lee, Hyang Woo ^a  

^a Sungkyunkwan University   (South Korea)

^b Konyang University   (South Korea)

Author keywords

Cell cycle; Cell proliferation; Transmethylase inhibitor; Transmethylation

Indexed keywords

CARRIER PROTEIN; CDKN1A PROTEIN, HUMAN; CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; DNA; ENZYME INHIBITOR; LUCIFERASE; METHYLTRANSFERASE; OLIGOSACCHARIDE; THYMIDINE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIVISION; CELL STRAIN 3T3; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; FLOW CYTOMETRY; GENETIC TRANSFECTION; GENETICS; HELA CELL; HUMAN; IMMUNOBLOTTING; LIVER; METABOLISM; MOUSE; SWINE;

3T3 CELLS; ANIMALS; CARRIER PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA; ENZYME INHIBITORS; FLOW CYTOMETRY; G0 PHASE; G1 PHASE; HELA CELLS; HUMANS; IMMUNOBLOTTING; LIVER; LUCIFERASES; METHYLTRANSFERASES; MICE; OLIGOSACCHARIDES; S PHASE; SWINE; THYMIDINE; TRANSFECTION;

EID: 0036691780     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/bf02976603     Document Type: Article

References (30)

1. Aarbakke, J., Miura, G. A., Prytz, P. S., Bessesen, A., Slordal, L., Gordon, R. K. and Chiang, P. K., Induction of HL-60 cell differentiation by 3-deaza-(+/-)-aristeromycin, an inhibitor of S-adenosylhomocysteine hydrolase. Cancer Res., 46, 5469-5472 (1986).
2. Aletta, J. M., Cimato, T. R. and Ettinger, M. J., Protein methylation: a signal event in post-translational modification. Trends Biochem. Sci., 23, 89-91 (1998).
3. Chen, D., Ma, H., Hong, H., Koh, S. S,, Huang, S. M., Schurter, B.T., Aswad, D. W. and Stallcup, M. R., Regulation of transcription by a protein ethyltransferase. Science, 284, 2174-2177 (1999).
4. Chiang, P. K., Burbelo, P. D., Brugh, S. A., Gordon, R. K., Fukuda, K. and Yamada, Y., Activation of collagen IV gene expression in F9 teratocarcinoma cells by 3-deazaadenosine analogs. Indirect inhibitors of methylation. J. Biol. Chem. 267, 4988-4991 (1992).
5. Draetta, G. F., Mammalian G1 cyclins. Curr. Opin. Cell Biol., 6, 842-846 (1994).
6. Dulic, V., Kaufmann, W. K., Wilson, S. J., Tlsty, T. D., Lees, E., Harper, J. W., Elledge, S. J. and Reed, S. I., p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell, 76, 1013-1023 (1994).
7. El-Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Canman, C. E., Jackman, J., Pietenpol, J. A., Burrel, M., Hill, D. E., Wang, Y., Wiman, K. G., Mercer, W. E., Kastan, M. B., Kohn, K. W., Elledge, S. J., Kinzler, K. W. and Bogelstein, B., WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res., 54, 1169-1174 (1994).
8. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W. and Vogelstein, B., WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825 (1993).
9. Gu, Y., Turck, C. W. and Morgan, D. O., Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature, 336, 707-710 (1993).
10. Han, J. W., Ahn, S. H., Park, S. H., Wang, S. Y., Bae, G. U., Seo, D. W., Kwon, H. K., Hong, S., Lee, H. Y., Lee, Y. W. and Lee, H. W., Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin. Cancer Res., 60, 6068-6074 (2000).
11. Harper, J. W., Adam, G. R., Wei, N., Keyomarsi, K. and Elledge, S. J., The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805-816 (1993).
12. Hunter, T. and Pines, J., Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell, 79, 573-582 (1994).
13. King, R. W., Jackson, P. K. and Kirschner, M. W., Mitosis in transition. Cell, 79, 563-571 (1994).
14. Lawrence, F. and Robert-Gero, M., Natural and synthetic analogs of-S-adenosylhomocysteine and protein methylation. In: Protein Methylation. Paik, W. K. and Kim, S. (Eds) CRC Press, Boca Raton, Florida pp. 305-340 (1990).
15. Liu, S., Wolfe, M. S. and Borchardt R. T., Rational approaches to the design of antiviral agents based on S-adenosyl-L-homocysteine hydrolase as a molecular target. Antivir. Res. 19, 247-265 (1992)
16. Magee, T. and Marshall, C., New insights into the interaction of Ras with the plasma membrane. Cell, 98, 9-12 (1999).
17. Paik, W. K., Kim, S. and Lee H. W., Enzymology of protein methylation: recent development. In: Biological Methylation and Drug Design. Borchardt, R. T., Creveling, C. R. and Ueland, P. M. (Eds). Humana Press, Clifton, New Jersey, pp. 15-23 (1986).
18. Paik, W. K. and Kim, S., Reevaluation of enzymology of protein methylation. In: Protein Methylation. Paik, W. K. and Kim, S. (Eds) CRC Press, Boca Raton, Florida pp. 23-31 (1990).
19. Rice, J. C. and Allis, C. D., Histone methylation versus histone acetylation: new insights into epigenetic regulation. Curr. Opin. Cell Biol., 13, 263-273 (2001).
20. Scherr, C. J. and Roberts, J. M., Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev., 9, 1149-1163 (1995).
21. Seo, D. W., Moon, H. I., Han, J. W., Hong, S. Y., Lee, H. Y., Kim, S., Paik, W. K. and Lee, H. W., An endogenous proteinacious inhibitor in porcine liver for S-adenosyl-L-methionine dependent methylation reactions: identification as oligosaccharide-linked acyl carrier protein. Int. J. Biochem. Cell Biol., 32, 455-464 (2000)
22. Sherr, C. J., G1 phase progression: cycling on cue. Cell, 79, 551-555 (1994).
23. Siavoshian, S., Segain, J. P., Kornprobst, M., Bonnet, C., Cherbut, C., Galmiche, J. P. and Blottiere, H. M., Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. Gut, 46, 507-514 (2000).
24. Sowa, Y., Orita, T., Minamikawa-Hiranabe, S., Mizuno, T., Nomura, H. and Sakai, T., Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor. Cancer Res., 59, 4266-4270 (1999).
25. Ueland, P. M., Pharmacological and biochemical aspects of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase. Pharmacol. Rev., 34, 223-253 (1982).
26. Waga, S., Hannon, G. J., Beach, D. and Stillman, B., The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature, 369, 574-578 (1994).
27. Wang, H., Huang, Z. Q., Xia, L., Feng, Q., Erdjument-Bromage, H., Strahl, B. D., Briggs, S. D., Allis, C. D., Wong, J., Tempst, P. and Zhang, Y., Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science, 293, 853-857 (2001).
28. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R. and Beach, D., p21 is a universal inhibitor of cyclin kinases. Nature, 366, 701-704 (1993).
29. Xiong, Y., Zhang, H. and Beach, D., D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell, 71, 505-514 (1992).
30. Yoshida, M., Kijima, M., Akita, M. and Beppu, T., Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem., 265, 17174-17179 (1990).